The FDA has approved Otsuka Pharmaceutical’s SIMTRIYO (centanafadine) for the treatment of attention...
Continuing stimulants or switching to atomoxetine during pregnancy was associated with differing hea...
Children with attention-deficit/hyperactivity disorder (ADHD) who also have aggression problems migh...
